Article
β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
Oncogene - 1 Jun 2018
Saponaro Concetta, Sergio Sara, Coluccia Antonio, De Luca Maria, La Regina Giuseppe, Mologni Luca, Famiglini Valeria, Naccarato Valentina, Bonetti Daniela, Gautier Candice, Gianni Stefano, Vergara Daniele, Salzet Michel, Fournier Isabelle, Bucci Cecilia, Silvestri Romano, Passerini Carlo Gambacorti, Maffia Michele, Coluccia Addolorata Maria Luce
Abstract excerpt
Nuclear activated β-catenin plays a causative role in colorectal cancers (CRC) but remains an elusive therapeutic target. Using human CRC cells harboring different Wnt/β-catenin pathway mutations in APC/KRAS or β-catenin/KRAS genes, and both genetic and pharmacological knockdown approaches, we show that oncogenic β-catenin signaling negatively regulates the expression of NHERF1 (Na+/H+ exchanger 3 regulating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
